The #1 Nutrient Deficiency Causing Brain Fog & Dementia

Hyman explicitly states: 'I found she had a really high level of something called methylmalonic acid and homocysteine which are things that most doctors don't check but reflect your status of B12 which is methylmalonic acid and homocysteine which is the folate and even B6.' The case illustrates that reversible B-vitamin deficiency can present identically to progressive Alzheimer's disease at the clinical level. Professor Wurtman at MIT found citicoline helpful for synapse formation — also relevant to choline adequacy in the same B-vitamin family.

Professor Wurtman at MIT found that citicoline (CDP-choline) is especially helpful for synapse formation — making it not just a precursor for acetylcholine but a direct structural support for new synaptic connections. Eggs are the richest dietary source (~125 mg per large egg), followed by liver, sardines, and oysters. Hyman recommends checking individual intake via an app before assuming adequacy.

The '1' in Ketoflex 12/3 stands for 12-hour minimum fast; the '3' stands for stopping eating 3 hours before bed. The fasting window allows the glymphatic system (the brain's waste-clearance system that operates primarily during sleep) to function optimally. Insulin must be low for the brain to make its own ketones — in insulin-resistant patients, high insulin actively blocks ketogenesis, creating both a glucose and a ketone deficit simultaneously. This double energy failure is visible on PET scan as the signature hypometabolic pattern of Alzheimer's.

The blood panel should include: homocysteine, methylmalonic acid, vitamin D (25-OH), fasting insulin and glucose/HOMA-IR, hsCRP, full hormone panel (estradiol, progesterone, testosterone, pregnenolone, thyroid), heavy metals (mercury, lead) via provocation challenge, mycotoxin panel (urine), Lyme and co-infections if indicated, B12, omega-3 index, zinc, magnesium, CoQ10, lipoic acid. The cognitive test identifies subjective cognitive impairment — a 10-year prodromal stage before MCI — when intervention produces near-100% reversal rates.

Bredesen specifically distinguishes sleep apnea from upper airway resistance syndrome — the latter causes partial airway obstruction without complete apnea events, produces significant desaturation, and triggers adrenaline release that causes middle-of-night awakening. These patients often report 'I just wake up for no reason at 3 AM' — the adrenaline surge is the reason. The treatment pathway differs from classic sleep apnea and is often missed by standard overnight polysomnography.

Hyman cites Paul Clayton (Oxford) observing that Henry VIII had better soil nutrition than modern humans — we have a triple whammy: depleted soils, processed food crowding out vegetables, and insufficient fiber/phytonutrient intake. Flavanols (in strawberries, grapes) and flavonoids (in blueberries) are both subclasses of the 25,000 phytochemicals in plant foods. The 'rainbow plate' heuristic ensures intake across multiple phytochemical families.

Bredesen distinguishes aerobic training (drives BDNF, neurogenesis, blood flow), strength training (complementary mechanisms, muscle-brain crosstalk via myokines), and neuromuscular coordination training (distinct pathway). KAATSU bands create partial blood flow restriction that stimulates vascular remodeling, resulting in improved blood flow to both muscles and brain post-training. EWOT adds supplemental oxygen during exercise to maximize the brain's energy delivery during the training session.

Just as Covid-19 compresses the body's inflammatory cascade into two weeks, Alzheimer's runs the same cascade over 20 years. The brain responds to insults — herpes simplex, P. gingivalis from gum disease, mold toxins, insulin resistance, hormonal loss — by producing amyloid as an antimicrobial agent. As long as those insults persist, the brain keeps downsizing. The therapeutic implication is to find and address each insult rather than suppress the amyloid. Bredesen showed this biochemically: inhibiting the corticotropin-releasing factor CRF1 receptor in the hippocampus improved both amyloid and tau in lab models, confirming that the stress pathway itself drives the pathology.

Type 1 patients need anti-inflammatory protocols — identifying and resolving gut permeability, oral pathogens, metabolic syndrome — plus resolvins. Type 1.5 patients need aggressive insulin sensitization (diet, exercise, fasting) and reduction of advanced glycation end-products. Type 2 patients need trophic factor repletion: hormonal optimization (estradiol, progesterone, testosterone, pregnenolone), vitamin D to optimal levels, B12, NGF, BDNF support through exercise and specific supplements. Most patients have contributions from multiple subtypes simultaneously, requiring all vectors to be addressed.

Even patients who do not snore and do not meet full criteria for obstructive sleep apnea can have significant nocturnal desaturations due to upper airway resistance syndrome. Bredesen's recommendation: have patients wear a pulse oximeter overnight; if readings drop below 96%, investigate further. Wearables like Apple Watch now provide sufficient oximetry data. Low progesterone (particularly in perimenopausal and postmenopausal women) compounds the problem by disrupting deep sleep architecture, creating a second mechanism by which hormone loss increases Alzheimer's risk.

Progesterone is especially critical for detoxification — it is a key driver of the body's detox apparatus. When estrogen and progesterone drop sharply (as in surgical menopause or natural perimenopause), women begin re-releasing stored toxins including mercury that had been sequestered in fat tissue for decades. This creates a simultaneous loss of trophic support AND a surge of neurotoxic insult, explaining why so many women in their 50s present with their first cognitive symptoms. Bredesen refers patients to BHRT specialists including Dr. Anne Hathaway and Dr. Prudence Hall for bioidentical hormone optimization.

Mercury (second only to plutonium as a neurotoxin) accumulates particularly in individuals from industrial cities — Hyman cites Pittsburgh patients exposed to coal ash — and in those with high seafood intake. Standard blood mercury levels miss total body burden; challenge testing with a chelating agent is needed to quantify tissue accumulation. Individuals with APOE4, methylation gene variants, and poor detoxification genetics accumulate mercury disproportionately. Bredesen estimates mercury accounts for approximately 3-5% of all Alzheimer's cases — still millions of Americans — and those patients respond dramatically to mercury detoxification.

The neuroradiologist reviewing the before-and-after scans reportedly said they had never seen such changes in their entire career. The functional improvement corresponded to actual volumetric changes: hippocampal volume increased, frontal and parietal lobe volumes improved. EEG and evoked response testing also showed objective electrophysiological improvement. The most likely mechanism is synaptogenesis — the brain rebuilding functional synaptic connections once the biochemical environment is restored. Neurons were not lost yet in most of these patients; what was lost was synaptic efficiency, which is reversible.